This event is being delivered in partnership with bioMérieux.
Addressing antimicrobial resistance (AMR) remains a global healthcare priority, as it risks effective management of acute infections, cancer care, and chronic disease management. Despite a WHO global action plan, and development of national action plans, to address AMR, there remain gaps in our policy, research, and clinical practice to combat this threat. Not least of these are in the field of infection-related diagnostics where there remain issues with constructive alignment of clinical need, technological answers, and policy commitment. In this webinar, Amelia Worley of DHSC will give us an overview of the diagnostic commitment in the UK National Action Plan for Antimicrobial Resistance; and Dr Luke Moore will explore the gaps and consider approaches for collaborative solutions to optimising diagnostics for AMR.
This event will be chaired by Dr Noha El Sakka OBE, RCPath Vice President for Communications.
This event will take place at 12:30pm and last approximately 1 hour.
CPD
This meeting is worth 1 CPD point (self credited).
Our speakers
Dr Luke Moore
Dr Moore is an Infectious Diseases Physician and Clinical Microbiologist with special interests in critical care infections, antimicrobial resistance, and healthcare systems. He holds a PhD in this field, 2 Masters degrees in Public Health and in Clinical Microbiology, both with distinction, and he is a Fellow of both the Royal College of Pathologists and the Royal College of Physicians. Dr Moore's current research focuses on the epidemiology of and interventions for outbreak control and antimicrobial stewardship, and he has published over 200 peer reviewed manuscripts. Dr Moore is an associate editor for the Journal of Hospital Infection, West London Lead for infectious diseases, microbiology, and virology training, and provides undergraduate and post graduate education across a range of degree courses.
Dr Noha El Sakka OBE
Dr El Sakka obtained a PhD in 2005 at the University of Aberdeen, followed by 2 years of post-doctoral research in the field of infection. Following completion of the FRCPath and Medical Microbiology training in 2015, Dr El Sakka was appointed a Consultant Microbiologist at NHS Grampian and an Honorary Clinical Senior Lecturer at the University of Aberdeen. She held the role of Director of Medical Microbiology and Virology service in Grampian between 2017-2023, and is currently the Director of Laboratory service in Grampian.
She was appointed to various national roles including Specialist Advisor to Scotland CMO and to the Scottish Government (2018-23), Chair of the Scottish Clinical Virology Consultants Group and Chair of the Scottish Diagnostic Virology Group. In December 2021, she was also elected a Fellow of the Royal College of Physicians in Edinburgh.
In addition to her role as the RCPath Vice President for Communications, Dr El Sakka is also a member of the RCPath Scotland Regional Council and a member of the Joint Medical Microbiology and Virology Speciality Advisory Committee and is the RCPath country advisor for Egypt.
In June 2022, Dr El Sakka was awarded an Officer of the Most Excellent Order of the British Empire (OBE) in the Queen's Birthday Honours list for her services to the NHS and the COVID-19 response
